Literature DB >> 14950210

The chemical approach to the control of tuberculosis.

H H FOX.   

Abstract

Entities:  

Keywords:  TUBERCULOSIS/therapy

Mesh：

Year:  1952        PMID： 14950210     DOI： 10.1126/science.116.3006.129

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

1.  [Tuberculostatic activity of certain pyridazones].

Authors:  N P BUU-HOI; R RIPS; R ROYER
Journal:  Experientia       Date:  1956-06-15

2.  Studies in experimental ocular tuberculosis. XVII. The effect of isoniazid in the normal, nonimmune rabbit.

Authors:  A C WOODS; B BECKER; R M WOOD
Journal:  Trans Am Ophthalmol Soc       Date:  1953

3.  Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.

Authors:  Tali H Reingewertz; Tom Meyer; Fiona McIntosh; Jaryd Sullivan; Michal Meir; Yung-Fu Chang; Marcel A Behr; Daniel Barkan
Journal:  Antimicrob Agents Chemother       Date:  2020-01-27       Impact factor: 5.191

Review 4.  Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Authors:  Sumit Chakraborty; Kyu Y Rhee
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

5.  The possible mechanisms of action of (-)deprenyl in Parkinson's disease.

Authors:  J Knoll
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

6.  Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.

Authors:  Evelyn Koeche Schroeder; Luiz Augusto Basso; Diógenes Santiago Santos; Osmar Norberto de Souza
Journal:  Biophys J       Date:  2005-05-20       Impact factor: 4.033

7.  Isoniazid pharmacokinetics in children treated for respiratory tuberculosis.

Authors:  H S Schaaf; D P Parkin; H I Seifart; C J Werely; P B Hesseling; P D van Helden; J S Maritz; P R Donald
Journal:  Arch Dis Child       Date:  2005-06       Impact factor: 3.791

8.  Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis.

Authors:  Deepak Almeida; Eric Nuermberger; Rokeya Tasneen; Ian Rosenthal; Sandeep Tyagi; Kathy Williams; Charles Peloquin; Jacques Grosset
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

9.  Use of pyrazinamide (aldinamide) in the treatment of tuberculous lymphadenopathy and draining sinuses; a preliminary report.

Authors:  J W V CORDICE; L M HILL; L T WRIGHT
Journal:  J Natl Med Assoc       Date:  1953-03       Impact factor: 1.798

10.  Isoniazid activation defects in recombinant Mycobacterium tuberculosis catalase-peroxidase (KatG) mutants evident in InhA inhibitor production.

Authors:  Chih-Jen Wei; Benfang Lei; James M Musser; Shiao-Chun Tu
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.